Literature DB >> 7595723

Response to 13-cis-retinoic acid plus interferon alfa-2a in two patients with therapy-refractory advanced renal cell carcinoma.

J Buer, M Probst, A Ganser, J Atzpodien.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7595723     DOI： 10.1200/JCO.1995.13.10.2679

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

1.  Capecitabine in the treatment of metastatic renal cell carcinoma.

Authors:  K Oevermann; J Buer; R Hoffmann; A Franzke; A Schrader; T Patzelt; H Kirchner; J Atzpodien
Journal:  Br J Cancer       Date:  2000-09       Impact factor: 7.640

Review 2.  Peroxisome Proliferator-Activated Receptors (PPAR)γ Agonists as Master Modulators of Tumor Tissue.

Authors:  Daniel Heudobler; Michael Rechenmacher; Florian Lüke; Martin Vogelhuber; Tobias Pukrop; Wolfgang Herr; Lina Ghibelli; Christopher Gerner; Albrecht Reichle
Journal:  Int J Mol Sci       Date:  2018-11-09       Impact factor: 5.923

Review 3.  Clinical Efficacy of a Novel Therapeutic Principle, Anakoinosis.

Authors:  Daniel Heudobler; Michael Rechenmacher; Florian Lüke; Martin Vogelhuber; Sebastian Klobuch; Simone Thomas; Tobias Pukrop; Christina Hackl; Wolfgang Herr; Lina Ghibelli; Christopher Gerner; Albrecht Reichle
Journal:  Front Pharmacol       Date:  2018-11-28       Impact factor: 5.810
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.